We are live on ! Find out more
MDNA

Medicenna Therapeutics Corp. Common Shares
MDNA

Delisted

MDNA was delisted on the 1st of November, 2023.

Back to rankings

1 hedge funds and large institutions have $145K invested in Medicenna Therapeutics Corp. Common Shares in 2024 Q2 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
1
Holders Change
+1
Holders Change %
–
% of All Funds
0.01%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
OP
ORG Partners
Indiana
+$145K

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
OP
1
ORG Partners
Indiana
$145K +$145K +100,000 New

MDNA Hedge Fund Activity: Q2 2024 in Review

1 of the 6,925 institutional investors tracked by Wall St. Rank reported a position in Medicenna Therapeutics Corp. Common Shares (MDNA) for Q2 2024, worth a combined $145K.

Buyers outnumbered sellers: 1 fund opened new MDNA positions and 0 closed out — a net gain of 1 holder — while 0 added to existing stakes and 0 trimmed.

The largest buyer was ORG Partners, opening a new position worth an estimated $145K.

  • 1 institutional investor held Medicenna Therapeutics Corp. Common Shares (MDNA) as of Q2 2024, up from 0 in Q1 2024.
  • Funds reported $145K of Medicenna Therapeutics Corp. Common Shares stock for Q2 2024.
  • 1 fund opened new Medicenna Therapeutics Corp. Common Shares positions in Q2 2024 and 0 closed out, a net change of +1 holder.
  • The largest Medicenna Therapeutics Corp. Common Shares buyer in Q2 2024 was ORG Partners, an estimated $145K added.

Based on aggregated 13F filings for Q2 2024.